Related Experiment Video

Updated: May 23, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
04:30

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

Monitoring calcific aortic valve disease: the role of biomarkers

G Latsios1, D Tousoulis, E Androulakis

  • 11st Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece. glatsios@hotmail.com

Current Medicinal Chemistry
|April 12, 2012
PubMed

Insights

Calcific aortic valve disease is an active biological process, not just passive degeneration. Research highlights inflammation, oxidized lipids, and bone formation as key features, with ongoing study into risk factors and biomarkers.

Area of Science:

  • Cardiovascular Medicine
  • Pathology
  • Biochemistry

Background:

  • Calcific aortic valve disease (CAVD) is a prevalent condition in the elderly, contributing to significant morbidity and mortality.
  • Historically viewed as passive calcification, CAVD is now understood as an active biological process.
  • Key histological features include inflammation, oxidized lipids, and extracellular matrix remodeling leading to bone formation.

Purpose of the Study:

  • To review the current understanding of calcific aortic valve disease.
  • To identify established and potential risk factors for calcific aortic stenosis.
  • To explore the utility of advanced monitoring tools and biomarkers for risk stratification and prognosis.

Main Methods:

  • Literature review of recent studies on calcific aortic valve disease.
  • Analysis of histological hallmarks and pathological mechanisms.
  • Examination of epidemiological data on risk factors.
  • Assessment of emerging diagnostic and prognostic tools.

Main Results:

  • CAVD involves active biological pathways, including inflammation and lipid oxidation.
  • Established risk factors include lipids, hypertension, male gender, renal failure, and diabetes.
  • Molecular imaging and biomarkers show potential for improved risk stratification and prognosis assessment, though their roles are still under investigation.

Conclusions:

  • Calcific aortic valve disease is an active, complex pathological process.
  • Further research is needed to fully elucidate the role of biomarkers and molecular imaging in clinical practice.
  • Improved risk stratification and prognosis assessment are crucial for managing patients with CAVD.

More Related Videos

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...